The interaction of HMGB1 with RAGE in the airways of patients with COPD promotes inflammation, fibroblast proliferation, chemotaxis and metalloproteinase synthesis and sequentially leads to tissue remodelling associated with airflow limitation and emphysema, such as airway smooth muscle thickening and fibrosis [37]. Here, AGER is linked to chronic obstructive pulmonary disease.